JMIR Res Protoc. 2018 Feb 26;7(2):e51. doi: 10.2196/resprot.9118.
Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study.
JMIR research protocols
Lixin Song, Kaitlyn L Dunlap, Xianming Tan, Ronald C Chen, Matthew E Nielsen, Rebecca L Rabenberg, Josephine K Asafu-Adjei, Bridget F Koontz, Sarah A Birken, Laurel L Northouse, Deborah K Mayer
Affiliations
Affiliations
- School of Nursing, University of North Carolina, Chapel Hill, NC, United States.
- Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
- University of North Carolina, Chapel Hill, NC, United States.
- School of Medicine, Duke University, Durham, NC, United States.
- School of Nursing, University of Michigan, Ann Arbor, MI, United States.
PMID: 29483070
PMCID: PMC5847815 DOI: 10.2196/resprot.9118
Abstract
BACKGROUND: This project explores a new model of care that enhances survivorship care planning and promotes health for men with localized prostate cancer transitioning to posttreatment self-management. Survivorship care planning is important for patients with prostate cancer because of its high incidence rate in the United States, the frequent occurrence of treatment-related side effects, and reduced quality of life (QOL) for both men and their partners. A key component of comprehensive survivorship care planning is survivorship care plans (SCPs), documents that summarize cancer diagnosis, treatment, and plans for follow-up care. However, research concerning the effectiveness of SCPs on patient outcomes or health service use has thus far been inconclusive. SCPs that are tailored to individual patients' needs for information and care may improve effectiveness.
OBJECTIVE: This study aims to examine the feasibility of an enhanced survivorship care plan (ESCP) that integrates a symptom self-management mHealth program called Prostate Cancer Education and Resources for Couples (PERC) into the existing standardized SCP. The specific aims are to (1) examine the feasibility of delivering ESCPs and (2) to estimate the magnitude of benefit of ESCPs.
METHODS: We will use a two-group randomized controlled pretest-posttest design and collect data at baseline (T1) and 4 months later (T2) among 50 patients completing initial treatment for localized prostate cancer and their partners. First, we will assess the feasibility of ESCP by recruitment, enrollment, and retention rates; program satisfaction with the ESCP; and perceived ease of use of the ESCP. To achieve the secondary aim, we will compare the ESCP users with the standardized SCP users and assess their primary outcomes of QOL (overall, physical, emotional, and social QOL); secondary outcomes (reduction in negative appraisals and improvement in self-efficacy, social support, and health behaviors to manage symptoms); and number of visits to posttreatment care services between T1 and T2. We will assess the primary and secondary outcomes using measurements with sound psychometrical properties. We will use a qualitative and quantitative mixed methods approach to achieve the research aims.
RESULTS: This project is ongoing and will be completed by the end of 2018.
CONCLUSIONS: The results from this study will help design a definitive randomized trial to test the efficacy of the ESCPs, a potentially scalable program, to enhance supportive care for prostate cancer patients and their families.
©Lixin Song, Kaitlyn L Dunlap, Xianming Tan, Ronald C Chen, Matthew E Nielsen, Rebecca L Rabenberg, Josephine K Asafu-Adjei, Bridget F Koontz, Sarah A Birken, Laurel L Northouse, Deborah K Mayer. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.02.2018.
Keywords: Patient Reported Outcome Measures; caregiver; mHealth; prostate cancer; survivorship; symptom, randomized trial
References
- Br J Cancer. 2013 May 14;108(9):1784-9 - PubMed
- Qual Life Res. 2011 Apr;20(3):371-81 - PubMed
- BJU Int. 2012 Dec;110(11):1690-5 - PubMed
- Psychooncology. 2012 Jan;21(1):72-81 - PubMed
- Qual Life Res. 2014 Oct;23(8):2309-17 - PubMed
- J Clin Oncol. 2011 Feb 1;29(4):362-8 - PubMed
- Int J Aging Hum Dev. 2000;51(1):5-29 - PubMed
- J Adv Nurs. 2013 Nov;69(11):2572-83 - PubMed
- Cancer Nurs. 2013 May-Jun;36(3):E7-E14 - PubMed
- Int J Med Inform. 2010 Apr;79(4):e18-23 - PubMed
- J Oncol Pract. 2012 Jul;8(4):e80-6 - PubMed
- J Cancer Surviv. 2011 Dec;5(4):337-44 - PubMed
- Am J Epidemiol. 2011 Mar 15;173(6):676-82 - PubMed
- Urology. 2000 Dec 20;56(6):899-905 - PubMed
- Psychooncology. 2010 Sep;19(9):909-22 - PubMed
- Oncol Nurs Forum. 2015 Mar;42(2):183-92 - PubMed
- J Chronic Dis. 1987;40(5):373-83 - PubMed
- J Clin Oncol. 2002 Oct 1;20(19):4050-64 - PubMed
- BMC Fam Pract. 2014 May 13;15:94 - PubMed
- J Clin Nurs. 2015 May;24(9-10):1367-79 - PubMed
- Rev Urol. 2013;15(4):161-77 - PubMed
- Am J Public Health. 2009 Dec;99(12):2123-7 - PubMed
- ANS Adv Nurs Sci. 1988 Oct;11(1):76-90 - PubMed
- Psychooncology. 2011 Feb;20(2):155-64 - PubMed
- J Clin Oncol. 1993 Mar;11(3):570-9 - PubMed
- Chronic Illn. 2013 Jun;9(2):145-55 - PubMed
- J Cancer Surviv. 2014 Dec;8(4):595-602 - PubMed
- Cancer. 2015 Apr 1;121(7):978-96 - PubMed
- BMC Cancer. 2013 Feb 26;13:89 - PubMed
- J Natl Cancer Inst. 2009 Jun 16;101(12):888-92 - PubMed
- J Cancer Surviv. 2015 Dec;9(4):683-91 - PubMed
- J Cancer Surviv. 2011 Jun;5(2):132-41 - PubMed
- Cancer. 2012 Nov 15;118(22):5679-87 - PubMed
- Eur Urol. 2014 May;65(5):856-64 - PubMed
- BMC Cancer. 2012 Jul 24;12:312 - PubMed
- N Engl J Med. 2008 Mar 20;358(12):1250-61 - PubMed
- J Cancer Educ. 2015 Jun;30(2):312-8 - PubMed
- J Clin Oncol. 2007 Sep 20;25(27):4171-7 - PubMed
- CA Cancer J Clin. 2014 Jul-Aug;64(4):225-49 - PubMed
- J Gerontol Nurs. 2012 Jul;38(7):38-43 - PubMed
- Psychooncology. 2013 Feb;22(2):475-9 - PubMed
- J Clin Oncol. 2015 Nov 1;33(31):3550-9 - PubMed
- Holist Nurs Pract. 2013 May-Jun;27(3):140-7 - PubMed
- Patient Educ Couns. 2010 Dec;81 Suppl:S100-10 - PubMed
- Cancer. 2007 Dec 15;110(12):2809-18 - PubMed
- J Clin Oncol. 2011 Dec 20;29(36):4755-62 - PubMed
- Semin Oncol Nurs. 2011 Nov;27(4):300-8 - PubMed
- Patient Educ Couns. 2009 Nov;77(2):179-86 - PubMed
- J Natl Cancer Inst. 2014 Sep 22;106(11):null - PubMed
- BMC Cancer. 2008 Aug 08;8:226 - PubMed
Publication Types
Grant support